Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 13/20 | 0.48 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4476347 | 1.00 | SRD5A2 (0.48) | SRD5A2SRD5A1AR | |
| SCHEMBL4476341 | 1.00 | SRD5A2 (0.48) | SRD5A2SRD5A1AR | |
| SCHEMBL4483689 | 0.87 | SRD5A2 (0.42) | SRD5A2SRD5A1AR | |
| SCHEMBL4483686 | 0.87 | SRD5A2 (0.42) | SRD5A2SRD5A1AR | |
| SCHEMBL4466306 | 0.86 | SRD5A2 (0.46) | SRD5A2SRD5A1AR | |
| SCHEMBL4466311 | 0.86 | SRD5A2 (0.46) | SRD5A2SRD5A1AR | |
| SCHEMBL4471672 | 0.86 | SRD5A2 (0.44) | SRD5A2SRD5A1 | |
| SCHEMBL4472551 | 0.86 | SRD5A2 (0.44) | SRD5A2SRD5A1 | |
| SCHEMBL4471676 | 0.86 | SRD5A2 (0.44) | SRD5A2SRD5A1 | |
| SCHEMBL4472555 | 0.86 | SRD5A2 (0.44) | SRD5A2SRD5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050131005-A1 | 4-azasteroid derivatives as androgen receptor modulators | WANG JIABING (US) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131005-A1 | 4-azasteroid derivatives as androgen receptor modulators | AR, NR5A1, NR3C1 | SRD5A2 9/4885SRD5A1 5/4885AR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.